BioCentury | Jun 9, 2016
Distillery Therapeutics

Therapeutics: GFT2I repeat domain containing 1 (GTF2IRD1); transforming growth factor β receptor II (TGFβ-RII; TGFBR2)

...levels of GTF2IRD1 correlated with disease progression and poor survival. In a mouse model of GTF2IRD1-positive...
...steps could include identifying and testing TGFβ-RII inhibitors in models of GTF2IRD1-positive breast cancer. TARGET/MARKER/PATHWAY: GFT2I repeat domain containing 1 (GTF2IRD1)...
Items per page:
1 - 1 of 1